Analysed BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) News Sources
RBC Capital Lowers its Price Target on Bicycle Therapeutics plc (BCYC) to $7 from $11
04-04-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Rising Sharply in Wednesday Trading
01-04-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading
25-03-2026
yahoo.com
After Plunging 20.2% in 4 Weeks, Here's Why the Trend Might Reverse for Bicycle Therapeutics (BCYC)
24-03-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Climb in Monday Trading
23-03-2026
yahoo.com
Bicycle Therapeutics (BCYC) Loses 19.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
23-03-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Fall in Friday Trading; Drop Over 2% for Week
20-03-2026
yahoo.com
Bicycle Therapeutics Announces Oral and Poster Presentations at the AACR Annual Meeting 2026
18-03-2026
yahoo.com
What is the current price of BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ)?
The current price of BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) is $4.94.
BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) absolute price change since previous trading day?
The absolute price change of BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) since the previous trading day is $-0.03.
BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) percentage price change since previous trading day?
The percentage price change of BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) since the previous trading day is -0.6036%.
What is the most recent average sentiment score for BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ)?
The most recent average sentiment score for BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ)?
The most recent sentiment for BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) is .
SEC-8K** Filing Available For BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.